L. Hami
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 8
-
- CAR-T cell therapy research 4
- Cancer Cells and Metastasis 3
- Neutropenia and Cancer Infections 2
-
- Virus-based gene therapy research 3
-
- Immunotherapy and Immune Responses 4
-
- Glycosylation and Glycoproteins Research 2
-
- Neuroblastoma Research and Treatments 2
- Co-authors
- Elizabeth J. ShpallRoy B. JonesWilbur A. FranklinPablo J. CagnoniChristopher HoganStewart R. CraigE.J. ShpallScott I. Bearman
- Cited by
- HematologyOncologyGenetics
- Journals
- Blood (3 papers)Journal of Clinical Oncology (2 papers)Hematology/Oncology Clinics of North America (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
L. Hami
20 papers receiving 431 citations
Peers
Comparison fields: 5 of 57
- Hematology 192
- Oncology 219
- Genetics 71
- Cancer Research 66
- Immunology 92
Countries citing papers authored by L. Hami
This map shows the geographic impact of L. Hami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Hami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Hami more than expected).
Fields of papers citing papers by L. Hami
This network shows the impact of papers produced by L. Hami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Hami. The network helps show where L. Hami may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L. Hami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 44 | |
| 2 | 2004 | 1 | |
| 3 | 2004 | 1 | |
| 4 | 2003 | 15 | |
| 5 | 1999 | 43 | |
| 6 | 1998 | 5 | |
| 7 | TRANSPLANTATION OF CANCER PATIENTS RECEIVING HIGH DOSE CHEMOTHERAPY WITH EX VIVO EXPANDED CORD BLOOD CELLS | 1998 | 16 |
| 8 | 1997 | 17 | |
| 9 | Comparison of retroviral-mediated gene transfer into cultured human CD34+ hematopoietic progenitor cells derived from peripheral blood, bone marrow, and fetal umbilical cord blood. | 1997 | 6 |
| 10 | 1996 | 53 | |
| 11 | 1996 | 27 | |
| 12 | 1996 | 48 | |
| 13 | Use of amifostine in bone marrow purging. | 1996 | 16 |
| 14 | 1995 | 49 | |
| 15 | 1995 | 7 | |
| 16 | 1994 | 5 | |
| 17 | 1994 | 52 | |
| 18 | 1994 | 2 | |
| 19 | 1992 | 7 | |
| 20 | Detection of minimal residual breast cancer in bone marrow. | 1992 | 7 |
About L. Hami
L. Hami is a scholar working on Hematology, Oncology, Immunology, Genetics and Virology, having authored 21 papers that have together received 459 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (8 papers), CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (4 papers), Virus-based gene therapy research (3 papers), Cancer Cells and Metastasis (3 papers), Glycosylation and Glycoproteins Research (2 papers), Neuroblastoma Research and Treatments (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Hematology (192 citations), Oncology (219 citations), Genetics (71 citations), Cancer Research (66 citations) and Immunology (92 citations). L. Hami has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Elizabeth J. Shpall, Roy B. Jones, Wilbur A. Franklin, Pablo J. Cagnoni, Christopher Hogan, Stewart R. Craig, E.J. Shpall, Scott I. Bearman, Salomon M. Stemmer and Ursula M. Gehling. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematology/Oncology Clinics of North America, Current Opinion in Hematology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.